Diversity content roundup for National Minority Health Month

Every April is National Minority Health Month, organized by the U.S. Department of Health and Human Services. This month is intended to highlight the focus on improving the health of racial and ethnic minorities by reducing health disparities and increasing equal access to care.

Continue reading

Asthma insights from 37,000 patients [whitepaper]

Asthma is a condition that can impact anyone — and currently, it affects over 26.5 million people in the United States. In spite of available treatments, asthma is responsible for 1.3 million emergency room visits and over 3,500 deaths every year. Additionally, asthma’s impact is not evenly distributed; the condition impacts a disproportionate number of women, children, and minority populations, ...

Continue reading

How to find clinical trials near you

At any given time, there are hundreds of thousands of research studies listed on ClinicalTrials.gov actively looking for patients both in the United States and across the globe. However, the multitude of options available does not necessarily mean it’s easy for interested individuals to find opportunities they are eligible for. That’s why we created Antidote Match™, a clinical trial search tool ...

Continue reading

Optimization for site performance [one-pager]

Enrolling patients in clinical trials requires more than just effective outreach strategies. Even with strong recruitment, delays at the site level may cause potential participants to lose interest, while overwhelming sites with low-quality referrals can waste valuable time and resources.

Continue reading

What are IWRS and IRT in clinical research?

Interactive Web Response Systems (IWRS) and Interactive Voice Response Systems (IVRS) are technologies used by research sites to manage patient enrollment, patient randomization, and study drug supplies. Collectively, these technologies can be referred to as Interactive Response Technologies (IRTs) or Randomization and Trial Supply Management (RTSM). These systems are a critical piece of every ...

Continue reading

Webinar recap: Kidney Action Week webinar featuring Antidote’s Rich Towne, PharmD

The annual Kidney Action Week is a virtual event put on by the American Kidney Fund designed to bring the entire kidney health community together for a week of amazing and informative content on all things related to kidney health. The event is filled with discussions, Q&As, webinars, and more — and this year, Antidote was thrilled to be involved!

Continue reading

National Kidney Month: What to know about IgA nephropathy

Each year in March, the National Institute of Diabetes and Digestive and Kidney Diseases puts on National Kidney Month, a month dedicated to raising awareness about kidney health and conditions. Chronic kidney disease, a grouping of conditions that damage the kidneys, impacts around 37 million Americans, and millions of others are considered to be at an increased risk.

Continue reading

An overview of key hemophilia facts

The rare, inherited blood disorder hemophilia is estimated to impact approximately 20,000 individuals in the United States, and over 400,000 worldwide. Currently, there is no cure for hemophilia — but through ongoing research, medical experts are continually learning more about the disease.

Continue reading

Antidote’s learnings from over 1,900 depression patients [whitepaper]

Depression, also known as clinical depression, Major Depressive Disorder, or MDD, is estimated to impact one out of six adults at some point in their lifetime, making it one of the most common mental disorders in the United States. It is estimated that the cost of depression totals $100 billion annually. While there are treatments available, finding the optimal one can place a significant burden ...

Continue reading

Understanding viral load and hepatitis B infections

Hepatitis B, sometimes abbreviated to HBV, is a liver infection that is one of the most serious in the world. If left untreated, hepatitis B can cause fibrosis, cirrhosis, hepatocellular carcinoma, and end-stage liver disease.

Continue reading

Get our latest posts in your inbox